Scope Infection Lawsuit Patients across the United States have filed medical scope infection lawsuits after contaminated endoscopes and duodenoscopes allegedly transmitted dangerous bacterial infections during procedures such as ERCP, colonoscopy, and other endoscopic treatments.
Spinal Cord Stimulator Lawsuit Spinal cord stimulator lawsuits allege that implanted pain devices malfunctioned, migrated, or caused nerve damage, often forcing patients to undergo revision or removal surgery.
Gabapentin Dementia Lawsuit Gabapentin dementia lawsuits are being investigated against Pfizer and other drug manufacturers following studies linking the widely prescribed medication to an increased risk of dementia, Alzheimer's disease and mild cognitive impairment. Learn about the allegations, recent research, lawsuit updates and potential settlement compensation.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Chlorpyrifos Parkinsonโs Disease Lawsuit Chlorpyrifos lawsuits are being investigated for individuals diagnosed with Parkinsonโs disease after direct, residential, occupational or Gulf War pesticide exposure.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Opdivo Could Extend Life of Mesothelioma Victims: Study February 3, 2021 Martha Garcia Add Your CommentsMesothelioma is a rare type of cancer caused by exposure to asbestos, and most individuals have a very short life expectancy by the time it is diagnosed. However, the findings of a new study indicate the cancer drug Opdivo may play a critical role in helping individuals with mesothelioma survive longer.In a study presented at the World Conference on Lung Cancer, British researchers indicate that patients who have mesothelioma and have exhausted traditional forms of treatment may survive months longer by taking Opdivo, providing signals for an important new treatment for the disease.Researchers included 332 patients in a clinical trial whose tumors were still growing after receiving chemotherapy, and the patients were not able to have surgery to treat their mesothelioma. A total of 221 patients were given Opdivo and 111 were given a placebo every two weeks for 12 months.Learn More AboutMesothelioma LawsuitsExposure to asbestos can cause the development of mesothelioma. Lawsuits have been filed nationwide against asbestos manufacturers.Learn MoreSEE IF YOU QUALIFY FOR COMPENSATIONLearn More AboutMesothelioma LawsuitsExposure to asbestos can cause the development of mesothelioma. Lawsuits have been filed nationwide against asbestos manufacturers.Learn MoreSEE IF YOU QUALIFY FOR COMPENSATIONOpdivo, also known as nivolumab, is an immunotherapy drug approved to treat several other types of cancer. Last year, the FDA approved a combination of Opdivo and Yervoy to treat mesothelioma, despite earlier concerns regarding side effects, such as heart conditions and immune-related adverse events. It is the first drug approved for mesothelioma treatment in 16 years.In the new study, patients who were given Opdivo had an increased chance of survival compared to placebo patients. The findings suggest Opdivo made the disease more stable for patients who relapsed after receiving standard cancer treatment.Patients treated with Opdivo survived 9.2 months, compared to those given the placebo, who only survived 6.6 months longer. Furthermore, the risk of their cancer progressing was reduced by 39% and their cancer did not worsen for at least three months compared with 1.8 months in the placebo group.Mesotheliomaย is a particularly deadly form of cancer, as it is often at a very late stage by the time it is diagnosed. The only known cause is exposure to asbestos particles, and the cancer is often diagnosed decades later.Although most uses of asbestos have been banned in the United States, new mesothelioma cases continue to be diagnosed among former workers exposed to the toxic fibers, as well as children and family members who breathed the fibers carried home on work clothing or in the hair.Asbestos lawsuitsย have been one of the longest-running mass torts in the United States, involving thousands of claims brought against companies that manufactured or sold products containing the substance.Roughly 3,000 people are diagnosed with mesothelioma in the United States each year. Currently only 7% of people with mesothelioma survive the disease for five years or more. Patients are typically treated with chemotherapy, surgery or radiotherapy. Until now, there has been no treatment than can significantly improve outcomes for patients.This is the first study to indicate a treatment and offer improved survival for patients with mesothelioma that have relapsed after chemotherapy, researchers claim.“This trial shows clear evidence of benefit and marks a major breakthrough in the treatment of mesothelioma, a disease where there are currently very few options for patients when first-line chemotherapy has stopped working and prognosis is often very poor,โ the researchers wrote.The findings were presented at the World Conference on Lung Cancer and are considered preliminary until published in a peer reviewed journal. Written by: Martha GarciaHealth & Medical Research WriterMartha Garcia is a health and medical research writer at AboutLawsuits.com with over 15 years of experience covering peer-reviewed studies and emerging public health risks. She previously led content strategy at The Blogsmith and contributes original reporting on drug safety, medical research, and health trends impacting consumers. Tags: Asbestos, Cancer, Mesothelioma, OpdivoMore Mesothelioma Lawsuit Stories EPA Asbestos Risk Assessment Finds Firefighters, Construction Workers Face Highest Risks April 18, 2024 EPA Bans Last Uses of Toxic Asbestos in the United States March 19, 2024 U.S. Government Is Falling Behind Inspecting Federal Buildings for Toxic Asbestos, GAO Report Warns March 11, 2024 0 Comments URLThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes NoPost Comment I authorize the above comments be posted on this pageWeekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings.Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermΔ MORE TOP STORIES Pesticide Parkinson’s Disease Lawsuit Filed Against Chlorpyrifos Manufacturers (Posted: 2 days ago)A man’s lawsuit blames pesticides for his development of Parkinson’s disease after living near nurseries in California for nearly 20 years.MORE ABOUT: CHLORPYRIFOS PARKINSONโS DISEASE LAWSUITChlorpyrifos Pesticide Exposure Detected in Infants, Raising New Neurotoxicity Concerns (11/03/2026)Chlorpyrifos Ban Takes Effect Across EU as Studies Link Pesticide Exposure to Parkinsonโs Disease (10/01/2026)Parkinson’s Disease Lawsuit Filed Against Chlorpyrifos Manufacturers (09/23/2026) Olympus Wrongful Death Lawsuit Judge Calls for Quick Resolution (Posted: 3 days ago)A wrongful death lawsuit filed against Olympus Medical over an alleged medical scope infection could be ready for trial in about a year.MORE ABOUT: SCOPE INFECTION LAWSUITOlympus Scope Problems Lead to FDA Import Warning (10/27/2026)Fujifilm and Olympus Scope Infection Risks Highlight Growing Need for Advanced Disinfection Systems: Report (10/19/2026)Olympus Medical Device Warning Letter Follows FDA Inspections of Six Manufacturing Facilities (10/16/2026) Lawyers Outline Process for Settling Bard PowerPort Lawsuits After Bellwether Trials (Posted: 4 days ago)Attorneys in Bard PowerPort lawsuits have asked a federal judge to suspend pretrial proceedings while the parties engage in settlement negotiations seeking to resolve the litigation.MORE ABOUT: BARD POWERPORT LAWSUITBard PowerPort Infection Lawsuit Claims Catheter Fractures Harbored Bacteria (11/03/2026)Fourth Bard PowerPort Bellwether Case Set for Trial Dec. 1, as Third Gets Underway (10/14/2026)Judge Clears Bard PowerPort Lawsuit for Trial, Rejecting Motion for Summary Judgment (10/02/2026)
EPA Asbestos Risk Assessment Finds Firefighters, Construction Workers Face Highest Risks April 18, 2024
U.S. Government Is Falling Behind Inspecting Federal Buildings for Toxic Asbestos, GAO Report Warns March 11, 2024
Pesticide Parkinson’s Disease Lawsuit Filed Against Chlorpyrifos Manufacturers (Posted: 2 days ago)A man’s lawsuit blames pesticides for his development of Parkinson’s disease after living near nurseries in California for nearly 20 years.MORE ABOUT: CHLORPYRIFOS PARKINSONโS DISEASE LAWSUITChlorpyrifos Pesticide Exposure Detected in Infants, Raising New Neurotoxicity Concerns (11/03/2026)Chlorpyrifos Ban Takes Effect Across EU as Studies Link Pesticide Exposure to Parkinsonโs Disease (10/01/2026)Parkinson’s Disease Lawsuit Filed Against Chlorpyrifos Manufacturers (09/23/2026)
Olympus Wrongful Death Lawsuit Judge Calls for Quick Resolution (Posted: 3 days ago)A wrongful death lawsuit filed against Olympus Medical over an alleged medical scope infection could be ready for trial in about a year.MORE ABOUT: SCOPE INFECTION LAWSUITOlympus Scope Problems Lead to FDA Import Warning (10/27/2026)Fujifilm and Olympus Scope Infection Risks Highlight Growing Need for Advanced Disinfection Systems: Report (10/19/2026)Olympus Medical Device Warning Letter Follows FDA Inspections of Six Manufacturing Facilities (10/16/2026)
Lawyers Outline Process for Settling Bard PowerPort Lawsuits After Bellwether Trials (Posted: 4 days ago)Attorneys in Bard PowerPort lawsuits have asked a federal judge to suspend pretrial proceedings while the parties engage in settlement negotiations seeking to resolve the litigation.MORE ABOUT: BARD POWERPORT LAWSUITBard PowerPort Infection Lawsuit Claims Catheter Fractures Harbored Bacteria (11/03/2026)Fourth Bard PowerPort Bellwether Case Set for Trial Dec. 1, as Third Gets Underway (10/14/2026)Judge Clears Bard PowerPort Lawsuit for Trial, Rejecting Motion for Summary Judgment (10/02/2026)